PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 64 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $18,146 | -6.2% | 18,592 | 0.0% | 0.00% | – |
| Q4 2022 | $19,336 | -71.1% | 18,592 | -68.3% | 0.00% | – |
| Q3 2022 | $67,000 | -72.7% | 58,592 | -55.3% | 0.00% | -100.0% |
| Q2 2022 | $245,000 | -37.2% | 131,125 | +1.8% | 0.00% | 0.0% |
| Q1 2022 | $390,000 | -12.6% | 128,745 | +9.1% | 0.00% | 0.0% |
| Q4 2021 | $446,000 | +471.8% | 117,985 | +686.6% | 0.00% | – |
| Q3 2021 | $78,000 | +36.8% | 15,000 | 0.0% | 0.00% | – |
| Q2 2021 | $57,000 | -63.0% | 15,000 | -75.0% | 0.00% | -100.0% |
| Q1 2021 | $154,000 | +23.2% | 60,000 | +20.0% | 0.00% | – |
| Q4 2020 | $125,000 | +66.7% | 50,000 | +354.5% | 0.00% | -100.0% |
| Q1 2018 | $75,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
| Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
| CM Management, LLC | 649,400 | $193,521 | 0.20% |
| BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
| WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
| NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
| TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
| Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |